CMO Formulation – Procurement Best Practices & Sourcing Strategies

1. Executive Summary
1.1. Global Market Analysis
1.2. Supply Market Outlook
1.3. Demand Market Outlook
1.4. ELINT’s Recommendations for an ideal Strategy
1.5. Category Opportunities and Risks
1.6. Negotiation Leverage
1.7. Talking Points to Business
1.8. COVID-19 Impact
2. Market Analysis
2.1. Global CMO Formulations: Market Overview
2.2. Global CMO Market: Drivers and Constraints
2.3. Global CMO Formulation Overview
3. Industry Analysis
3.1. Day One Analysis
3.2. Category Portfolio Analysis
3.3. AQSCIR
3.4. Porter’s Five Forces Analysis
3.5. SWOT Analysis
3.6. Key Industry Trends and Market Shifts
4. Market Monitoring Insights
4.1. Cost Structure for Drug Product CMO Formulation
4.2. Emerging Market Sourcing: Cost Saving Initiative
5. Innovation & Trends
5.1. Restricted Access Barrier System (RABS)
5.2. Continuous Manufacturing Technology
5.3. Case Study on CMO‘s Technology Innovations
6. Supplier Analysis
6.1. Key Global Suppliers: Service Portfolio
6.2. Key Regional Suppliers: Capabilities
6.3. Top Suppliers in Key Supply Locations: Capabilities
6.4. Key Supplier profiles
7. Procurement Best Practices
7.1. Big Pharma’s Preferred Business Models
7.2. Big Pharma: Generic Outsourcing Case study
7.3. Generic Pharma: Emerging Market Sourcing
7.4. CMO Mark-up
8. RFP Builder
8.1. RFP Builder
9. Sustainability Initiatives and Best Practices
9.1. Sustainability Initiatives
9.2. Sustainability Best Practices – Case Studies